دورية أكاديمية

The Evolving Role of Nucleotide-binding Oligomerisation Domain-like Receptor Pyrin Domain 3 Inflammasome Activation in Vascular Endothelial Cells: A Review.

التفاصيل البيبلوغرافية
العنوان: The Evolving Role of Nucleotide-binding Oligomerisation Domain-like Receptor Pyrin Domain 3 Inflammasome Activation in Vascular Endothelial Cells: A Review.
المؤلفون: Abas R; Department of Cardiovascular Sciences, University of Leicester, Glenfield Hospital, United Kingdom.; Department of Human Anatomy, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Selangor, Malaysia., Basir R; Department of Human Anatomy, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Selangor, Malaysia., Mohd Thani S; Department of Human Anatomy, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Selangor, Malaysia., Salihan S; Department of Human Anatomy, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Selangor, Malaysia., Saat A; Department of Human Anatomy, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Selangor, Malaysia., Mohamad Zainal NH; Department of Human Anatomy, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Selangor, Malaysia., Mohamad Asri SF; Department of Human Anatomy, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Selangor, Malaysia., Ab Razak NI; Department of Human Anatomy, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Selangor, Malaysia., Mohd Nor NH; Department of Human Anatomy, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Selangor, Malaysia., Kamaruddin NA; Department of Anatomy, Faculty of Medicine, Universiti Kebangsaan Malaysia Medical Centre, Kuala Lumpur, Malaysia.
المصدر: The Malaysian journal of medical sciences : MJMS [Malays J Med Sci] 2022 Apr; Vol. 29 (2), pp. 8-17. Date of Electronic Publication: 2022 Apr 21.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Universiti Sains Malaysia Press Country of Publication: Malaysia NLM ID: 101126308 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1394-195X (Print) Linking ISSN: 1394195X NLM ISO Abbreviation: Malays J Med Sci Subsets: PubMed not MEDLINE
أسماء مطبوعة: Publication: [Pulau Pinang, Malaysia] : Universiti Sains Malaysia Press
Original Publication: [Kubang Kerian, Kelantan, Malaysia] : School of Medical Sciences, Universiti Sains Malaysia,
مستخلص: In the vascular wall, defence against pathogenic damage requires a group of monocytes, the endothelium, dendritic cells, macrophages and a subsequent involvement of pattern recognition receptors anticipating damage-associated molecular patterns (DAMPs) to initiate an innate immune response. The endothelium plays a crucial role in regulating the duration, location and extent of the inflammatory cascade to ensure a definitive immune defence. Molecular changes in the expression of chemokines and cell adhesion molecules ensure protective responses against infection and injury. The multiprotein oligomer complex nucleotide-binding oligomerisation domain (NOD)-like receptor pyrin domain 3 (NLRP3) inflammasome plays a key role in the activation of inflammatory processes in response to DAMPs and pattern-associated molecular patterns. As a result of NLRP3 inflammasome activation, caspase-1 is activated and interleukin-1β (IL-1β) is produced. Caspase-1 is the main mediator of inflammatory feedback to tissue injury, and it is engaged both in the initiation of the inflammatory response and in the induction of cell death. NLRP3 inflammasome promotes further inflammatory responses and pyroptosis in the vascular endothelium; thus, its optimum regulation is crucial in cardiovascular homeostasis. This review outlines our current perception of the role of NLRP3 in vascular endothelial cells.
Competing Interests: Conflicts of Interest None.
(© Penerbit Universiti Sains Malaysia, 2022.)
References: Nat Immunol. 2008 Aug;9(8):847-56. (PMID: 18604214)
J Immunol. 2010 Jun 1;184(11):6335-42. (PMID: 20421639)
Inflammation. 2017 Apr;40(2):366-386. (PMID: 27924425)
Science. 2010 Jan 15;327(5963):291-5. (PMID: 20075244)
J Immunol. 2006 Apr 1;176(7):3877-83. (PMID: 16547218)
PLoS One. 2011 May 04;6(5):e19379. (PMID: 21573248)
Am J Cardiovasc Dis. 2011;1(3):244-54. (PMID: 22254202)
Annu Rev Genet. 2007;41:401-27. (PMID: 17666007)
Cell. 2013 Mar 28;153(1):272-272.e1. (PMID: 23540703)
Immunol Rev. 2015 May;265(1):35-52. (PMID: 25879282)
Arterioscler Thromb Vasc Biol. 2004 Jan;24(1):12-22. (PMID: 14604830)
Cell Death Differ. 2013 Sep;20(9):1149-60. (PMID: 23645208)
Nat Immunol. 2011 Mar;12(3):199-200. (PMID: 21321591)
Immunol Rev. 2015 May;265(1):1-5. (PMID: 25879279)
Oncotarget. 2017 Aug 24;8(53):91291-91305. (PMID: 29207644)
Int J Cardiol. 2014 Mar 15;172(2):e282-4. (PMID: 24439873)
J Immunol. 2011 Nov 1;187(9):4809-17. (PMID: 21940680)
Cell Physiol Biochem. 2017;42(6):2255-2266. (PMID: 28817808)
Proc Natl Acad Sci U S A. 2014 Jan 14;111(2):775-80. (PMID: 24379360)
Cell. 2008 Mar 7;132(5):818-31. (PMID: 18329368)
Front Immunol. 2021 Feb 25;12:617251. (PMID: 33717109)
Annu Rev Immunol. 2011;29:707-35. (PMID: 21219188)
PLoS One. 2009 Oct 14;4(10):e7446. (PMID: 19826485)
Stem Cell Rev Rep. 2021 Feb;17(1):266-277. (PMID: 32691370)
Immunol Rev. 2020 Sep;297(1):123-138. (PMID: 32770571)
Am J Physiol Cell Physiol. 2004 May;286(5):C1100-8. (PMID: 15075209)
Sci Rep. 2020 Mar 25;10(1):5386. (PMID: 32214150)
J Cell Physiol. 2003 Sep;196(3):430-43. (PMID: 12891700)
Thromb Haemost. 2009 Dec;102(6):1103-9. (PMID: 19967140)
Circulation. 2013 Aug 6;128(6):632-42. (PMID: 23838163)
Annu Rev Pathol. 2006;1:297-329. (PMID: 18039117)
Immunol Rev. 2015 May;265(1):6-21. (PMID: 25879280)
Mol Cell. 2002 Aug;10(2):417-26. (PMID: 12191486)
Blood. 2011 Aug 25;118(8):2366-74. (PMID: 21700772)
J Immunol. 2009 Jul 15;183(2):787-91. (PMID: 19570822)
Circ Res. 2012 Feb 17;110(4):560-8. (PMID: 22267843)
Clin Exp Immunol. 2011 Oct;166(1):1-15. (PMID: 21762124)
Eur J Psychol. 2015 May 29;11(2):295-310. (PMID: 27247658)
J Immunol Res. 2015;2015:828264. (PMID: 26355424)
Eur J Clin Invest. 2015 Feb;45(2):160-9. (PMID: 25496217)
Cell Death Differ. 2007 Sep;14(9):1583-9. (PMID: 17599094)
Curr Opin Struct Biol. 2014 Dec;29:17-25. (PMID: 25201319)
Biochim Biophys Acta. 2015 Feb;1853(2):396-408. (PMID: 25450976)
Toxicol Lett. 2016 Mar 30;246:7-16. (PMID: 26809137)
Science. 2013 Jul 12;341(6142):172-5. (PMID: 23765277)
فهرسة مساهمة: Keywords: NLRP3 inflammasome; endothelial cells; inflammation; vascular
تواريخ الأحداث: Date Created: 20220509 Latest Revision: 20220716
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC9036936
DOI: 10.21315/mjms2022.29.2.2
PMID: 35528818
قاعدة البيانات: MEDLINE
الوصف
تدمد:1394-195X
DOI:10.21315/mjms2022.29.2.2